Association between proton pump inhibitor use and mortality in patients with hepatocellular carcinoma receiving tyrosine kinase inhibitor

Gut. 2020 Sep 9:gutjnl-2020-321932. doi: 10.1136/gutjnl-2020-321932. Online ahead of print.
No abstract available

Keywords: antibody targeted therapy; hepatoma; proton pump inhibition.

Publication types

  • Letter